I liked the one today... where Ketchum said the 3 studies used targeted patients with relatively low TG levels... lower than the 200 - 500 being asked for on an expanded label. Did anyone else observe or know that?
I haven't heard a single argument this board has thought up that wasn't brought up today at the CC.
I didn't hear the CC, but what you said jibes with all of the exchanges I've had with SR - as in everything I sent him that we had found he and AMRN already knew about. They are definitely on top of this from every angle.